Search results
Pfizer (NYSE:PFE) Trading 1.3% Higher
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 1.3% on Tuesday . The company traded as high as $27.38 and last traded at $27.32. 8,155,528 shares changed hands during ...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 9 hours agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
The Motley Fool via AOL· 3 days agoWhen it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 4 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19...
Kansas AG Kris Kobach suing Pfizer for ‘misleading Kansans on COVID vaccine’
KWCH· 4 days agoKansas Attorney General Kris Kobach announced that he’s suing Pfizer “for misleading claims it made...
Sarepta’s Elevidys secures US label expansion for DMD
Pharmaceutical Technology via Yahoo Finance· 4 hours agoJust a week after Pfizer revealed a Phase III trial failure for its mini-dystrophin gene therapy for...
Analysts Set Pfizer Inc. (NYSE:PFE) Price Target at $35.86
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Get Free Report) has been assigned an average rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat Ratings ...
Pfizer Inc. (NYSE:PFE) Position Increased by V Square Quantitative Management LLC
ETF DAILY NEWS· 6 days agoV Square Quantitative Management LLC increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 260.1% in the 4th quarter, according to the company in its ...
Vanguard Group Inc. Sells 210,463 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoVanguard Group Inc. lessened its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 0.0% during the fourth quarter, according to its most recent filing with the Securities ...
Merck’s vaccine approval poses threat to one of Pfizer’s top-selling products
Market Watch· 4 days ago“We’ll provide protection that’s broader than anything that’s out there,” Art Hirt, senior vice...
